Hypokalemia: Clinical Trials

38 trials for Hypokalemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

23 completed, 6 unknown, 3 recruiting, 2 active not recruiting. 13 Not applicable, 13 Phase 4, 3 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable13Completed 10, Active not recruiting 1, Recruiting 1, Unknown 1
Phase 413Completed 5, Unknown 3, Terminated 2, Active not recruiting 1, Enrolling by invitation 1, Not yet recruiting 1
Phase 23Completed 2, Unknown 1
Phase 12Completed 1, Unknown 1

Follow Hypokalemia: new trials by email Literature Review of Hypokalemia trials Research Report on Hypokalemia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension
RFA -radiofrequency ablation, Adrenalectomy - Primary Aldosteronism Due to Conn Adenoma, Radiofrequency Ablation Treatment
Not applicableRecruitingUniversity Hospital, Toulouse1342026-06-052026-06-11
Combination Osilodrostat and Cabergoline in Cushing's Disease
osilodrostat, osilodrostat and cabergoline - Cushing Disease Due to Increased ACTH Secretion
Phase 4Enrolling by invitationUniversity of Basrah502026-05-112026-05-22
the Cardioprotective Effects of Improving Potassium Variability in Maintenance Hemodialysis Patients
Sodium Zirconium Cyclosilicate (SZC) - Chronic Kidney Disease on Hemodialysis, Hypokalemia
Phase 4Not yet recruitingQianfoshan Hospital1002025-03-012024-12-16
Management of Hypokalemia in Intensive Care Patients
Implementation of hypokalemia treatment algorithm - Hypokalemia, Intensive Care Unit (ICU)
Not applicableCompletedAnadolu University2002024-09-012026-09-22
Tissue Sodium Quantification in Patients With Primary Aldosteronism: See Sodium to Treat
23NaMRI Scan, Potassium Chloride (KCl) - Hypertension, Primary Aldosteronism
RecruitingJens Titze802023-12-272025-06-06
CXCR4 Targeted PET Imaging in APA Preoperative Localization Diagnosis
CXCR4 - Aldosterone-Producing Adenoma
Not applicableUnknownZhongnan Hospital502023-05-302023-07-17
Comparison of a Low Dose to a Standard Dose of Insulin in Adult DKA in ICU to Reduce Metabolic Complications
Insulin 0.05 IU/kg/h, Insulin 0.10 IU/kg/h - Diabetic Ketoacidosis
Not applicableCompletedAssistance Publique - Hôpitaux de Paris1502022-08-162025-05-29
Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium
Cicletanine + magnesium, Cicletanine - Arterial Hypertension, Diabetes
Phase 1 / Phase 2UnknownNavitas Pharma242022-06-012021-09-05
Occurrence of Dyskalemia With Treatment for Hypertension
Fixed Dose Combination pill of Telmisartan 40mg and Amlodipine 5 mg - Hypertension, Potassium Imbalance
Phase 4CompletedNational Heart Foundation of Bangladesh10902022-01-152023-07-14
Artificial Intelligence Identified Dyskalemia Using Electrocardiogram (AIDE)
Artificial Intelligence identified Dyskalemia using Electrocardiogram (AIDE) system - Hyperkalemia, Hypokalemia
Not applicableCompletedNational Defense Medical Center, Taiwan149892022-01-012024-09-19
Description of the Clinical Outcomes of Hospitalized Patients With Heart Failure With Different Serum Potassium Levels
Hyperkalemia, Hypokalemia
CompletedAstraZeneca69502021-11-302023-07-10
Renal Tubular Disorders in Egyptian Children
Renal Tubular Disorders in Children
CompletedSohag University582021-04-232022-02-07
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: - Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension
RecruitingDuke University50002020-03-052026-08-21
Targeted Potassium Levels for Prevention of ICD Therapy
Targeted serum potassium level - Ventricular Arrhythmias and Cardiac Arrest, Implantable Defibrillator User
Phase 4Active not recruitingCopenhagen University Hospital, Rigshospitalet12002019-03-012025-05-09
Hypokalemia in Hospitalized Patients for Heart Failure in the Therapeutic Cardiac Failure Unit
Heart Failure
CompletedCentre Hospitalier Régional Metz-Thionville2502017-11-152019-02-04
Potassium Supplementation in CKD
Potassium Chloride, Potassium Citrate, Placebo - Renal Insufficiency, Chronic, Potassium Depletion
Not applicableActive not recruitingErasmus Medical Center5322017-07-012026-08-10
Hypomagnesemia Associated With Proton-Pump Inhibitor Use
proton pump inhibitor use - Proton Pump Inhibitor Adverse Reaction, Hypomagnesemia
CompletedChangi General Hospital2116722017-01-312020-06-11
Intravenous Fluids in Hospitalised Children
Plasmalyte Glucos 50 mg/mL, 0.45% saline in 5% dextrose - Hypokalemia, Hyponatremia
Phase 4CompletedUniversity of Oulu6602016-10-032019-08-22
Outcome of Patients With Primary Aldosteronism
Unilateral adrenalectomy in patients with unilateral disease - Primary Aldosteronism, Primary Aldosteronism Due to Aldosterone Producing Adenoma
UnknownChangi General Hospital6002016-10-012021-08-12
Preventing Metabolic Side Effects of Thiazide Diuretics With KMgCitrate
Potassium Magnesium Citrate (KMgCit), Potassium Chloride (KCl), Chlorthalidone - Hypertension
Not applicableCompletedUniversity of Texas Southwestern Medical Center612015-01-012023-10-25

Showing 20 of 38. Sign in to see all of them.

Narrower conditions

Hypertension (12)  ·  Heart Failure (6)  ·  Hyperaldosteronism (6)  ·  Hyperkalemia (6)  ·  Arrhythmias, Cardiac (5)  ·  Gitelman Syndrome (3)  ·  Renal Insufficiency, Chronic (3)  ·  Adrenal Insufficiency (2)  ·  Adrenocortical Adenoma (2)  ·  Heart Arrest (2)  ·  Hemophilia A (2)  ·  Hyponatremia (2)  ·  Menorrhagia (2)  ·  Pain (2)

Broader conditions

Nutritional and Metabolic Diseases (38)  ·  Water-Electrolyte Imbalance (38)  ·  Metabolic Diseases (37)  ·  Cardiovascular Diseases (20)  ·  Vascular Diseases (12)  ·  Endocrine System Diseases (11)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Heart Diseases (10)  ·  Adrenal Gland Diseases (9)  ·  Female Urogenital Diseases (9)  ·  Female Urogenital Diseases and Pregnancy Complications (9)  ·  Pathologic Processes (9)  ·  Urogenital Diseases (9)  ·  Male Urogenital Diseases (8)  ·  Adrenocortical Hyperfunction (7)

Interventions

Furosemide (3)  ·  Hydrochlorothiazide (3)  ·  Spironolactone (3)  ·  Aminocaproic Acid (2)  ·  Bosentan (2)  ·  Cefepime (2)  ·  Dexmedetomidine (2)  ·  Dopamine (2)  ·  Fosfomycin (2)  ·  Labetalol (2)  ·  Nifedipine (2)  ·  Osilodrostat (2)  ·  Oxycodone (2)  ·  Potassium Chloride (2)  ·  Potassium, Dietary (2)

Sponsors

Assistance Publique - Hôpitaux de Paris (4)  ·  Changi General Hospital (2)  ·  Larissa University Hospital (2)  ·  University of Oulu (2)  ·  Aga Khan University (1)  ·  Anadolu University (1)  ·  AstraZeneca (1)  ·  Baptist Health South Florida (1)  ·  Centre Hospitalier Régional Metz-Thionville (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Daniel Benjamin (1)  ·  Duke University (1)  ·  Erasmus Medical Center (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Indiana University (1)

Countries

France (8)  ·  United States (8)  ·  Singapore (4)  ·  Canada (2)  ·  China (2)  ·  Denmark (2)  ·  Finland (2)  ·  Greece (2)  ·  South Korea (2)  ·  Australia (1)  ·  Bangladesh (1)  ·  Brazil (1)  ·  Egypt (1)  ·  Iraq (1)  ·  Israel (1)

Top investigators

Anne Blanchard, MD, PhD (2)  ·  Filippos Triposkiadis, MD (2)  ·  Gregory Giamouzis, MD (2)  ·  Abbas A Mansour (1)  ·  Anwarul Haq, MD (1)  ·  Blanchard Anne, MD,PhD (1)  ·  Chi Hornik (1)  ·  Chi Hornik, PharmD (1)  ·  Christian Joens, MD, PhD (1)  ·  Damien Roux, PhD (1)  ·  David H Ellison, MD (1)  ·  Ewout J Hoorn, MD, PhD (1)  ·  Fazilatunnesa Malik, MBBS, FCPS (1)  ·  Haider A Alidrisi (1)  ·  Henning Bundgaard, Prof., DMSc (1)

Results publications

PMID 19562574, PMID 20837883, PMID 21111980, PMID 22146510, PMID 23339169, PMID 24107737, PMID 24485633, PMID 24614374, PMID 24949994, PMID 25190615, PMID 26039810, PMID 26926644, PMID 27522443, PMID 28137820, PMID 28290120, PMID 28495809, PMID 28779462, PMID 28993507, PMID 29084742, PMID 29271816, PMID 29435949, PMID 29677389, PMID 30790601, PMID 31317556, PMID 31369102, PMID 31548185, PMID 31814149, PMID 31849839, PMID 32206838, PMID 32324313, PMID 32497307, PMID 33029806, PMID 33058182, PMID 33104176, PMID 33107592, PMID 33903114, PMID 34302290, PMID 35370711, PMID 35491971, PMID 35609996, PMID 35998969, PMID 37467227, PMID 37846572, PMID 40779318, PMID 40879429, PMID 41247430, PMID 41507124, PMID 41923135, PMID 42803000

NIH funding

U54HD064382 (1)